POLYMED1,749.00

Poly Medicure Ltd.

· Pharma & Health
₹ CrorePeersPFIZERRAINBOWONESOURCEKIMSJUBLPHARMAVIJAYAINDGNGRANULESMcap ₹17,728 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt170.2177.6341.6341.6
Net Debt18.6-887.7-448.8-448.8
Total Debt/Equity0.120.060.110.11
Net Debt/Equity0.01-0.32-0.14-0.14
Total Debt/EBITDA0.480.390.770.77
Net Debt/EBITDA0.05-1.96-1.01-0.97
Interest Coverage (EBIT/Interest)26.0430.8617.8717.87
Total Debt/Total Capital %10.386.049.799.79
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.